APA (7th ed.) Citation

F, P., C, G., F, B., D, R., V, G., DM, F., . . . M, L. (2026). IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy. NPJ precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01389-y

Chicago Style (17th ed.) Citation

F, Pagano, et al. "IL-1-mediated Inflammation Promotes Metastatic Dissemination and Resistance to EGFR-targeted Therapy." NPJ Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01389-y.

MLA (9th ed.) Citation

F, Pagano, et al. "IL-1-mediated Inflammation Promotes Metastatic Dissemination and Resistance to EGFR-targeted Therapy." NPJ Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01389-y.